Age (median) (IQR) (yr) | 74 (65–80) | 75 (63–81) | .932a |
Male (No.) (%) | 36 (48.0) | 50 (48.3) | .596b |
Diabetes mellitus (No.) (%) | 18 (24.0) | 22 (22.9) | .868b |
Hypertension (No.) (%) | 39 (52.0) | 54 (56.3) | .580b |
Dyslipidemia (No.) (%) | 8 (10.7) | 15 (15.6) | .346b |
Atrial fibrillation (No.) (%) | 24 (32.0) | 24 (25.0) | .312b |
CAOD (No.) (%) | 11 (10.5) | 13 (13.5) | .834b |
Occlusion location (right) (No.) (%) | 35 (46.7) | 49 (51.0) | .570b |
Initial NIHSS score (median) (IQR) | 14 (8–18) | 12 (8–15) | .049a |
Time of treatment stage | | | |
Symptom onset to hospital arrival (median) (IQR) (min) | 171 (55–544) | 92 (42–258) | .082a |
Door to puncture (median) (IQR) (min) | 87 (63–107) | 142 (106–177) | <.001a |
Symptom onset to puncture (median) (IQR) (min) | 268 (145–665) | 254 (184–490) | .466a |
Procedure time (median) (IQR) (min) | 65 (49–86) | 59 (40–85) | .200a |
Radiologic and clinical outcome (No.) (%) | | | |
Successful recanalization (TICI 2b, 3) | 64 (85.3) | 79 (82.3) | .594b |
Good clinical outcome (3-m mRS 0–2) | 44 (58.7) | 59 (61.5) | .711b |
Excellent clinical outcome (3-m mRS 0–1) | 32 (42.7) | 35 (36.5) | .409b |